Pfizer Limited (NSE:PFIZER)

India flag India · Delayed Price · Currency is INR
5,080.30
+101.40 (2.04%)
May 22, 2025, 3:30 PM IST
15.92%
Market Cap 227.77B
Revenue (ttm) 24.54B
Net Income (ttm) 7.68B
Shares Out 45.75M
EPS (ttm) 167.79
PE Ratio 29.67
Forward PE 32.39
Dividend 35.00 (0.70%)
Ex-Dividend Date Jul 9, 2025
Volume 116,562
Average Volume 100,660
Open 4,935.00
Previous Close 4,978.90
Day's Range 4,850.00 - 5,169.00
52-Week Range 3,701.00 - 6,451.15
Beta 0.08
RSI 86.58
Earnings Date May 29, 2025

About Pfizer

Pfizer Limited engages in manufacturing, marketing, trading, and export of pharmaceutical products in India and internationally. It offers its products in various therapeutic areas, including neuro/CNS, hormones, cardiovascular, haemophilia, anti-infectives, gynecology, pain/analgesics, orthopedic, oncology, urology, anti-parasitic, gastro intestinal, vaccines, and respiratory, as well as vitamins, minerals, and nutrients. The company also offers internal medicine and anti-infectives services to hospitals and nursing homes. It serves healthcare... [Read more]

Sector Healthcare
Founded 1950
Employees 1,721
Stock Exchange National Stock Exchange of India
Ticker Symbol PFIZER
Full Company Profile

Financial Performance

In 2024, Pfizer's revenue was 24.54 billion, an increase of 11.87% compared to the previous year's 21.93 billion. Earnings were 7.68 billion, an increase of 39.23%.

Financial Statements

News

There is no news available yet.